AACR Pediatric Cancer Progress Report 2025
The inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of pediatric cancer.
Read the Report
The inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of pediatric cancer.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreA decade after launching AACR Project GENIE, the international data-sharing initiative is powering advances in cancer precision medicine.
Learn MoreChildhood acute lymphoblastic leukemia (ALL) is the most common type of pediatric cancer.
Learn MoreIn this episode, Suzanne Stone, an Emmy-winning storyteller, nonprofit champion, and the President and CEO of Livestrong, talks about her career path that brought her to Livestrong.
Listen and SubscribeAs people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowEarly registration is now open. Register by Monday, January 5, to receive the lowest rates.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
